Deep learning in next-generation vaccine development for infectious diseases
- PMID: 40641804
- PMCID: PMC12242420
- DOI: 10.1016/j.omtn.2025.102586
Deep learning in next-generation vaccine development for infectious diseases
Abstract
The landscape of vaccine development was changed in the genomic era with the help of computer science. Computer-aided vaccine epitope selection has become a foundation of rational vaccine design. Similarly, artificial intelligence (AI) is quickly transforming the vaccine development landscape. Deep learning (DL), a subset of AI, is used in the landscape of vaccine development in terms of its algorithms, tools, and technologies. This review article discussed the developmental history of the modern era of vaccine development strategies using both immunoinformatics with DL models, identification strategies of T cell epitopes and B cell epitopes through immunoinformatics and DL models, vaccine constructs development strategies using linker and adjuvant, and characterization strategies of vaccine construct using bioinformatics and immunoinformatics. Similarly, the article discusses different tools and technologies, from epitope mapping and vaccine construct development to characterization. Again, it also highlighted recent paradigm shifts, DL-based strategies in vaccine development, and different DL-based tools used for epitope mapping and vaccine construct development. However, integrated frameworks connecting the bioinformatics and DL approaches are rapidly progressing, which are necessary for DL-assisted epitope prediction and the subsequent steps for vaccine development. DL-assisted vaccine development is rapid and cost-effective, changing the scenario of next-generation vaccine development very fast.
Keywords: MT: Bioinformatics; deep learning; immunoinformatics; infectious diseases; next-generation vaccine.
© 2025 The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures






Similar articles
-
A deep learning approach to direct immunofluorescence pattern recognition in autoimmune bullous diseases.Br J Dermatol. 2024 Jul 16;191(2):261-266. doi: 10.1093/bjd/ljae142. Br J Dermatol. 2024. PMID: 38581445
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079. Health Technol Assess. 2024. PMID: 39046101 Free PMC article.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
Research status, hotspots and perspectives of artificial intelligence applied to pain management: a bibliometric and visual analysis.Updates Surg. 2025 Jun 28. doi: 10.1007/s13304-025-02296-w. Online ahead of print. Updates Surg. 2025. PMID: 40580377
References
-
- LeCun Y., Bengio Y., Hinton G. Deep learning. Nature. 2015;521:436–444. - PubMed
-
- Silver D., Schrittwieser J., Simonyan K., Antonoglou I., Huang A., Guez A., Hubert T., Baker L., Lai M., Bolton A., et al. Mastering the game of Go without human knowledge. Nature. 2017;550:354–359. - PubMed
-
- Schrittwieser J., Antonoglou I., Hubert T., Simonyan K., Sifre L., Schmitt S., Guez A., Lockhart E., Hassabis D., Graepel T., et al. Mastering Atari, Go, chess and shogi by planning with a learned model. Nature. 2020;588:604–609. - PubMed
Publication types
LinkOut - more resources
Full Text Sources